Transmissible Spongiform Encephalopathies

27-28 June 2006, Renaissance Penta Vienna, Austria

www.ibc-lifesci.com/tse




Do you know about the science and control of TSEs from the perspective of biopharmaceutical production?

Do you need to keep TSE infectivity out of various materials?

Are you aware of the latest progress towards developing low cost and viable testing methods to detect TSEs?

Do you have an overall understanding of TSE infection and disease progression?



If you answered no to any or all of the above, IBC Life Sciences inaugural event Transmissible Spongiform Encephalopathies is vital for you. Bringing together pioneering experts and key industry leaders in this field, this is your chance to learn the all the latest developments in this rapidly moving industry.



Find out more:

www.ibc-lifesci.com/tse



WHEN:



27 28 June 2006



WHERE:



Renaissance Penta Vienna, Austria



WHY:



o The first forum in Europe dedicated exclusively to TSEs

o Hear from 22 key speakers from industry and academia

o Join in interactive discussion opportunities with pioneer TSE experts

o Benefit from the extensive networking opportunities with like-minded biologics pioneers

o Learn from 8 case studies from experts with experience in the TSE field



For full programme details please visit:

www.ibc-lifesci.com/tse



WHO:



Prof. Adriano Aguzzi, Institute of Neuropathology, University Hospital of Zurich, Switzerland

Dr Robert Rohwer, Director Molecular Neurovirology Unit, University of Maryland, USA

Prof. James Ironside, Director of Laboratories, National CJD Surveillance Unit, University of Edinburgh , UK

Dr David M Asher, Chief, Laboratory of Bacterial, Parasitic and Unconventional Agents, Division of Emerging and Transfusion-Transmitted Diseases, Office of Blood Research and Review, CBER FDA, USA

Dr Sol Ruiz, Division of Biologicals and Biotechnology, Spanish Medicines Agency, Spain

Rapporteur for the TSE guideline at the European Medicines Agency and also for the TSE certification system at the European Pharmacopeia

Prof. Maurizio Pocchiari, Department of Cell Biology and Neurosciences, Istituto Superiore di Sanita, Italy



For full speaker programme and details please go to:

www.ibc-lifesci.com/tse



DONT MISS:



2 Pre-Conference Workshops



26 June 2006

Workshop A: Theoretical and Practical Considerations in Performing Virus

and TSE Clearance Studies

Workshop B: Virus and Prion Risk Management Strategies and QC Control

Tests for Biopharmaceutical Products



Post-Conference Briefing Day: Viral Safety



29 June 2006


Providing you with data driven case studies and the latest technological developments, this briefing day will allow you to discuss strategies and approaches for overcoming the technical challenges and regulatory hurdles associated with the validation of Biological Products



Key Speakers include:

o Dr Jim Robertson, National Institute for Biological Standards and Control, UK

o Dr Yuling Li, Human Genome Sciences Inc., USA

o Dr Kathryn Martin Remington, Cardinal Health, USA

o Dr Bin Yang, Genetech, USA

o Dr Thomas R. Kreil, Baxter BioScience, Austria



For more information, visit:

www.ibc-lifesci.com/tse



WANT TO KNOW MORE:



Web: www.ibc-lifesci.com/tse

Email: charlotte.garratt@informa.com

Phone: +44 (0) 20 7915 5055


We look forward to welcoming you to Vienna.


Kind regards


Louisa Pickering
Conference Producer